OEZVF yields 4.42% · PFE yields 6.13%● Live data
📍 OEZVF pulled ahead of the other in Year 1
Combined, OEZVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OEZVF + PFE for your $10,000?
VERBUND AG, together with its subsidiaries, generates, trades, and sells electricity to energy exchanges, traders, electric utilities and industrial companies, and households and commercial customers in Austria and internationally. It operates through Hydro, New Renewables, Sales, Grid, and All Other segments. As of December 31, 2021, the company operated hydropower plants with a capacity of 8,307 megawatts (MW); wind farms with a capacity of 418 MW; solar farms with a capacity of 3 MW; and thermal power plants with an electrical capacity of 1,013 MW. It also operates electricity transmission network in Austria, as well as long-distance gas pipeline and gas distribution network; trades and sells gas; and provides energy-related services. The company was formerly known as Österreichische Elektrizitätswirtschafts- Aktiengesellschaft and changed its name to VERBUND AG in 2010. VERBUND AG was founded in 1947 and is headquartered in Vienna, Austria.
Full OEZVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.